Drug management of hypertension in primary care
Intended for healthcare professionals
Clinical Previous     Next

Drug management of hypertension in primary care

Gwen Hall Diabetes Specialist Nurse in Primary Care/Clinical Educator, Visiting Fellow, University of Surrey

The management of hypertension in primary care continues to represent a significant burden on the NHS, both clinically and financially (Box 1). Recent estimates suggest that around 16 million people in the UK have hyper-tension (Blood Pressure Association 2005), which accounts for around 37 per cent of men and 34 per cent of women (Department of Health (DH) 2002). According to the World Health Organization (WHO), the global disease burden attributable to a systolic blood pressure of 115 mmHg or above is significant. It accounts for around seven million deaths each year (WHO 2005), 49 per cent of coronary heart disease cases and 62 per cent of strokes (Maryon-Davis et al 2005). A recent study showing that the burden of stroke is greater than that of heart disease highlights the significance of these figures (Rothwell et al 2005).

Primary Health Care. 16, 3, 27-31. doi: 10.7748/phc2006.04.16.3.27.c600

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more